CGAS and Alzheimer disease: Evidence from mouse tauopathy models and AD neural spheroids has shown that lamivudine can effectively suppress retrotransposon activation, attenuate neuroinflammation (especially TLR and cGAS activation), and preserve neuronal viability (Fig. 1) [100–102].